ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1831

Intestinal Inflammatory Regulation in Murine and Human Spondyloarthropathy Requires High-Affinity T Cell Receptor-Zeta Chain-Associated Protein (ZAP)70-Mediated Runt-Related Transcription Factor (Runx)3 Activity

Zaied Ahmed Bhuyan1, M. Arifur Rahman2, Muralidhara Maradana1, Ahmed Mehdi3, Giuliana Guggino4, Paul Leo5, Linda Rehaume1, Matthew Brown5, Francesco Ciccia4 and Ranjeny Thomas1, 1The University of Queensland Diamantina Institute, Brisbane, Australia, 2Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia, 3Diamantina Institute, The University of Queensland Diamantina Institute, Brisbane, Australia, 4Rheumatology Unit, University of Palermo, Palermo, Italy, 5Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), inflammatory bowel disease (IBD), mouse model and regulatory cells, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M088 ACR Abstract: Spondyloarthritis Incl PsA–Basic Science (1828–1833)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Loss of function RUNX3 variants are associated with ankylosing spondylitis (AS) risk but the mechanism is unknown. Disturbances in immune regulation, intestinal microbial dysbiosis and subclinical intestinal inflammation characterize AS, and flares in intestinal inflammation are associated with arthritis severity. Intestinal regulatory T cells (Foxp3+ Treg) limit inflammation, and TCRαβ+CD4+CD8+ cytotoxic T cells (CD4CTL) control intracellular bacteria at epithelial interfaces. CD4CTL develop in response to antigen presented by retinoic acid (RA)-producing dendritic cells. TGF-β and RA enhance CD4+ T cell Runx3 and suppress ThPOK for CD4CTL trans-differentiation. ZAP70W163C mutant (SKG) mice have reduced ZAP70 signaling, spondyloarthritis and ileitis. We investigated ZAP70 in Runx3 signaling and CD4CTL development.

Methods:

We isolated ileal intraepithelial and lamina propria lymphocytes and analysed Treg and CD4CTL. CD4CTL were generated in vitro by culture of OVA-specific DO11.10 and SKG.DO11.10 T cells with OVA peptide, TGF-b and RA, and in vivo by transfer of OVA-specific T cells to immune-deficient mice fed OVA. Differentially-expressed genes from terminal ileum of 8 naïve SKG and 3 BALB/c mice were assessed by RNA microarray (Illumina). We compared enrichment of Runx3-regulated genes uncovered by ChIP-seq and transcriptome analysis in SKG and BALB/c mice. T cells isolated from human colon, ileum and blood of 5 AS patients and 5 healthy controls (HC) were analyzed.

Results:

CD4CTL and Runx3 expression were reduced, while Foxp3+ pTreg were increased SKG relative to BALB/c ileum. Tissue resident memory T cell-associated genes e.g. Cd3e, Itgae, Ccl5, and Itgb7, and antigen processing and presentation genes e.g. H2-ab1, H2-Dma, H2-ea, Tap1, and H2-q8, were downregulated in SKG relative to BALB/c ileum. 36% of differentially-expressed genes are Runx3-regulated genes, previously identified by ChIP-Seq. The SKG ZAP70-mediated TCR loss of function prevented effective intestinal CD4CTL but not pTreg differentiation in context of TGF-β and RA in vitro and in vivo, resulting in Runx3 and ThPOK dysregulation. CD4CTL and their expression of perforin, IFN-g, NFAT and Runx3 were decreased in intestine and blood of AS patients compared with HC.

Conclusion:

High-affinity TCR-ZAP70 signaling is required for RUNX3-mediated intestinal CD4CTL differentiation and the balance with Foxp3+ Treg. Runx3 deficiency links intestinal pathology in mice and humans through CD4CTL. Since deficiency of CD4CTL cells with cytotoxic function should limit host control of intracellular pathobiont species, reduced TCR-ZAP70-RUNX3 is a key pathogenetic pathway in spondyloarthropathy.


Disclosure: Z. A. Bhuyan, None; M. A. Rahman, None; M. Maradana, None; A. Mehdi, None; G. Guggino, None; P. Leo, None; L. Rehaume, None; M. Brown, None; F. Ciccia, None; R. Thomas, Janssen, 2, 5,Dendright Pty Ltd, 6,Merck & Co., 2, 5.

To cite this abstract in AMA style:

Bhuyan ZA, Rahman MA, Maradana M, Mehdi A, Guggino G, Leo P, Rehaume L, Brown M, Ciccia F, Thomas R. Intestinal Inflammatory Regulation in Murine and Human Spondyloarthropathy Requires High-Affinity T Cell Receptor-Zeta Chain-Associated Protein (ZAP)70-Mediated Runt-Related Transcription Factor (Runx)3 Activity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/intestinal-inflammatory-regulation-in-murine-and-human-spondyloarthropathy-requires-high-affinity-t-cell-receptor-zeta-chain-associated-protein-zap70-mediated-runt-related-transcription-factor-runx/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intestinal-inflammatory-regulation-in-murine-and-human-spondyloarthropathy-requires-high-affinity-t-cell-receptor-zeta-chain-associated-protein-zap70-mediated-runt-related-transcription-factor-runx/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology